Hackers have access to documents related to authorized COVID-19 vaccines


023-vaccine-covid-19-species-drug-stock-virus-2020-injection-mrna-tests-modern-pfizer

Sarah Tew / CNET

For the latest news and information on the coronavirus epidemic, visit the WHO website.

Hackers were able to obtain approval documents COVID-19 vaccines after reaching the European Medicines Agency through a cyber attack. The attackers “illegally obtained” regulatory documents the coronavirus vaccine candidate nominated by biotechnology company BioNTech and pharmaceutical company Pfizer, BioNTech said in a statement on Wednesday.

The European Medicines Agency, which is responsible for reviewing the effectiveness of the vaccine, confirmed the hack in a statement, but did not want to provide further details during the ongoing study. According to the agency, the hack will not affect the schedule for releasing the vaccine.

BioNTech said its own servers are not affected and are unaware of the theft of personal information from 43,500 test subjects.

It is not clear who was behind the cyber attack, but hackers from other countries as well China, Russia North Korea has targeted pharmaceutical companies developing COVID-19 vaccines.

The The United Kingdom has launched a mass vaccination program on Tuesday, it became the first country to start shipping the vaccine widely. The program is expected to reach 4 million people by the end of December, using BioNTech and Pfizer vaccines, which 95% efficacy in clinical trials.

See also: Who will receive COVID vaccines first? CDC priorities and everything else we know

BioNTech did not respond to a request to comment on what vaccine details hackers had access to.

It was also targeted by hackers how the vaccine will be introduced – Emerging as a cold store supply chain company and targeting distributors who provide vaccinations to millions of people.

The UK’s National Cyber ​​Security Center said it supports vaccine research and helps protect against hackers. It is still investigating the infringement, the agency said in a statement.

“We are working with international partners to understand the impact of this case on the EU medicines regulator, but there is currently no evidence that the UK medicines regulator has been affected,” the agency said.

The information in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a doctor or other qualified health care provider if you have any questions about your health condition or your health goals.